首页> 外文学位 >Targeted polymer ultrasound contrast agents for molecular imaging.
【24h】

Targeted polymer ultrasound contrast agents for molecular imaging.

机译:用于分子成像的靶向聚合物超声造影剂。

获取原文
获取原文并翻译 | 示例

摘要

Cardiovascular disease (CVD) is a complex pathology that begins at the molecular and cellular levels, but typically manifests itself via high blood pressure, stroke or heart failure. Detecting CVD early in the disease process would allow for more effective treatment. Ultrasound provides inexpensive, real-time imaging of the body but needs to be coupled with a disease targeted ultrasound contrast agent (USCA) to provide insight into molecular events at specific pathologic tissues. Therefore, the specific goals of this work were to fabricate, and characterize a peptide-targeted polymer ultrasound contrast agent (USCA) designed to bind to Human Umbilical Vein Endothelial Cells (HUVECs) under flow conditions.;Spherical polymer UCSAs (average diameters ranging from 1-3 mum) were fabricated using a modified double emulsion technique by optimizing relevant processing parameters. The internal structure of the fabricated USCAs was classified as hollow or solid by correlating high frequency measurements of the normalized backscatter coefficient (NBC) with the expected differences from theoretical predictions of scattering by solid and hollow spheres. The fabricated polymer USCAs that were deemed hollow also exhibited high levels of echogenicity when exposed to diagnostic frequencies (5-10 MHz) of ultrasound. This process was selected for creating targeted USCAs.;A targeting strategy of physically incorporating the lipid-based ligand was investigated using a known polymer microsphere system in which the microspheres were characterized morphologically by SEM, proton nuclear magnetic resonance (HNMR), and zeta potential measurements. The surface architecture that led to significant binding was composed of 2000 Da molecular weight unliganded PEG-lipids and 3350 Da molecular weight liganded PEG-lipids. The mixed surface architecture was used in the polymer USCA system for coupling biotinylated peptide RGD (Arg-Gly-Asp) through avidin-biotin-bridging. RGD-targeted polymer USCA adhered to HUVEC after 30 min of static incubation. Under flow conditions at shear rates of 46, 62, and 108 s-1, the adherence of RGD-targeted polymer USCA increased with shear rate from 3 USCA/cell to 8 USCA/cell.;In conclusion, methods were developed to produce, and characterize polymer USCAs functionalized with physical incorporation techniques. These site-targeted polymer USCAs attached to HUVEC surfaces under flow. Thus, these targeted USCAs have demonstrated potential for molecular imaging of CVD.
机译:心血管疾病(CVD)是一种复杂的病理学,始于分子和细胞水平,但通常通过高血压,中风或心力衰竭表现出来。在疾病过程中尽早发现CVD将可以进行更有效的治疗。超声波可提供廉价的人体实时成像,但需要与针对疾病的超声造影剂(USCA)结合使用,以洞悉特定病理组织的分子事件。因此,这项工作的具体目标是制造和表征旨在在流动条件下与人脐静脉内皮细胞(HUVEC)结合的以肽为靶标的聚合物超声造影剂(USCA).;球形聚合物UCSA(平均直径范围为通过改进相关的加工参数,使用改进的双乳化技术制造了1-3毫米)。通过将归一化后向散射系数(NBC)的高频测量值与来自实心和空心球体散射的理论预测的预期差异相关联,可将制造的USCA的内部结构分为空心或实心。当暴露于超声的诊断频率(5-10 MHz)时,被视为中空的人造聚合物USCA也表现出高水平的回声性。选择此过程来创建靶向的USCA。;使用已知的聚合物微球系统研究了物理掺入基于脂质的配体的靶向策略,该系统通过SEM,质子核磁共振(HNMR)和Zeta电位对微球进行了形态表征测量。导致显着结合的表面结构由2000 Da分子量的未配体PEG-脂质和3350 Da分子量的配体PEG-脂质组成。混合的表面体系结构用于聚合物USCA系统中,以通过亲和素-生物素桥接将生物素化的肽RGD(Arg-Gly-Asp)偶联。静态温育30分钟后,靶向RGD的聚合物USCA附着在HUVEC上。在剪切速率分别为46、62和108 s-1的流动条件下,靶向RGD的聚合物USCA的附着力随剪切速率从3 USCA / cell增至8 USCA / cell而增加。并表征通过物理掺入技术功能化的聚合物USCA。这些定点的聚合物USCA在流动下附着于HUVEC表面。因此,这些靶向的USCA已显示出对CVD分子成像的潜力。

著录项

  • 作者

    Duncanson, Wynter Joia.;

  • 作者单位

    Boston University.;

  • 授予单位 Boston University.;
  • 学科 Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 233 p.
  • 总页数 233
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号